Evaluation of treatment response in patients with metastatic renal cell carcinoma: Role of state-of-the-art cross-sectional imaging

Venkata S. Katabathina, Nathalie Lassau, Ivan Pedrosa, Chaan S. Ng, Srinivasa R. Prasad

Research output: Contribution to journalArticle

11 Scopus citations

Abstract

Recent advances in genetics and oncology have led to development of a wide array of molecular therapeutics in the management of patients with metastatic renal cell carcinoma. These drugs have revolutionized the treatment of advanced disease by significantly improving patient outcomes. State-of-the-art cross-sectional imaging techniques play a seminal role in the evaluation of treatment response by providing reproducible, objective data, thereby permitting accurate quantification of tumor burden. Evolving functional imaging techniques such as perfusion and diffusion studies continue to advance the technology beyond assessing changes in tumor size and morphology.

Original languageEnglish (US)
Pages (from-to)70-81
Number of pages12
JournalCurrent Urology Reports
Volume13
Issue number1
DOIs
StatePublished - Feb 1 2012

Keywords

  • Arterial spin labeling
  • Computed tomography
  • Contrast-enhanced imaging
  • Functional imaging techniques
  • Magnetic resonance imaging
  • Metastatic renal cell carcinoma
  • Molecular therapeutics
  • Positron emission tomography
  • RECIST
  • Treatment response
  • Ultrasound

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Evaluation of treatment response in patients with metastatic renal cell carcinoma: Role of state-of-the-art cross-sectional imaging'. Together they form a unique fingerprint.

  • Cite this